|
Insider Trading: Amicus Therapeutics Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Amicus Therapeutics Inc since 2005.
The reporting company's ticker symbol is FOLD.
The reporting company's CIK number is 1178879.
The total value of stock buying since 2005 is $88,425,714.
The total value of stock sales is $128,885,355.
The total value of stock exercises is $285,250.
1 year stock price chart,
1 day stock price chart
FOLD 1 year chart FOLD 1 day chart
Figure 1. Monthly insider transaction values at Amicus Therapeutics Inc (FOLD) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
04 05 06 07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 -
Figure 2. Average prices of insider buys, sales, and option exercises at Amicus Therapeutics Inc (FOLD) in the past 24 months. See table 2 for insider transaction details.
04 05 06 07 08 09 10 11 12 01 2012 02 03 04 05 06 07 08 09 10 11 12 01 2013 02 03 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Amicus Therapeutics Inc (FOLD).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2013-03 | 25,000 | 85,000 | 0 | 0 | 0 | 0 |
| 2012-11 | 1,665 | 7,559 | 0 | 0 | 0 | 0 |
| 2012-07 | 2,949,581 | 18,582,360 | 0 | 0 | 0 | 0 |
| 2012-03 | 6,410,308 | 36,538,754 | 0 | 0 | 49,931 | 31,955 |
| 2011-08 | 10,000 | 42,000 | 0 | 0 | 0 | 0 |
| 2011-06 | 20,000 | 120,800 | 0 | 0 | 0 | 0 |
| 2011-05 | 0 | 0 | 2,250 | 16,875 | 2,250 | 1,435 |
| 2010-03 | 11,898 | 43,903 | 0 | 0 | 0 | 0 |
| 2009-11 | 20,000 | 82,600 | 0 | 0 | 0 | 0 |
| 2009-07 | 0 | 0 | 50,000 | 546,603 | 0 | 0 |
| 2009-06 | 0 | 0 | 9,998 | 101,327 | 0 | 0 |
| 2009-03 | 0 | 0 | 2,502 | 25,020 | 1,000 | 5,325 |
| 2009-02 | 0 | 0 | 9,408 | 92,977 | 0 | 0 |
| 2009-01 | 0 | 0 | 0 | 0 | 4,924 | 3,141 |
| 2008-12 | 0 | 0 | 4,573 | 38,985 | 20,098 | 12,822 |
| 2008-11 | 0 | 0 | 70,676 | 662,758 | 0 | 0 |
| 2008-10 | 0 | 0 | 96,043 | 1,083,800 | 40,000 | 119,240 |
| 2008-09 | 0 | 0 | 78,958 | 42,540,664 | 0 | 0 |
| 2008-08 | 0 | 0 | 179,212 | 2,806,588 | 1,401 | 892 |
| 2008-07 | 0 | 0 | 125,777 | 79,015,299 | 30,000 | 19,110 |
| 2008-06 | 0 | 0 | 15,000 | 163,741 | 0 | 0 |
| 2008-05 | 0 | 0 | 10,000 | 105,229 | 0 | 0 |
| 2008-04 | 0 | 0 | 41,950 | 453,327 | 20,000 | 12,740 |
| 2008-03 | 428,376 | 13,714,641 | 10,000 | 100,000 | 0 | 0 |
| 2008-02 | 1,292,086 | 12,832,012 | 35,500 | 355,702 | 22,083 | 14,088 |
| 2008-01 | 113,700 | 1,138,641 | 10,000 | 103,050 | 20,000 | 12,760 |
| 2007-12 | 0 | 0 | 0 | 0 | 15,000 | 9,570 |
| 2007-08 | 60,200 | 692,220 | 0 | 0 | 32,366 | 20,649 |
| 2007-07 | 119,000 | 1,356,351 | 0 | 0 | 0 | 0 |
| 2007-06 | 281,842 | 3,188,873 | 44,894 | 673,410 | 33,736 | 21,523 |
Go to page: 1
2
Table 2. Detailed insider stock purchases, sales, and option exercises
for Amicus Therapeutics Inc (FOLD)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2013-03-15 | Barer Sol J (Director) | Purchase | 25,000 | 3.40 | 85,000 |
| 2012-11-13 | Winterbottom Joan (SVP, Human Resources) | Purchase | 1,665 | 4.54 | 7,559 |
| 2012-07-17 | Glaxosmithkline Plc | Purchase | 2,949,581 | 6.30 | 18,582,360 |
| 2012-03-30 | Crowley John F (Chairman & CEO) | Option Exercise | 49,931 | .64 | 31,955 |
| 2012-03-07 | Sandell Scott D (10% Owner) | Purchase | 925,154 | 5.70 | 5,273,377 |
| 2012-03-07 | Barrett M James (Director) | Purchase | 925,154 | 5.70 | 5,273,377 |
| 2012-03-07 | Perry Mark W (10% Owner) | Purchase | 1,140,000 | 5.70 | 6,498,000 |
| 2012-03-07 | Barris Peter J (10% Owner) | Purchase | 1,140,000 | 5.70 | 6,498,000 |
| 2012-03-07 | Kramlich C Richard (10% Owner) | Purchase | 1,140,000 | 5.70 | 6,498,000 |
| 2012-03-07 | Newhall Charles W Iii (10% Owner) | Purchase | 1,140,000 | 5.70 | 6,498,000 |
| 2011-08-11 | Crowley John F (Chairman & CEO) | Purchase | 10,000 | 4.20 | 42,000 |
| 2011-06-17 | Crowley John F (Executive Chairman) | Purchase | 20,000 | 6.04 | 120,800 |
| 2011-05-24 | Valenzano Ken (VP, Pharmacology & Biology) | Sale | 2,250 | 7.50 | 16,875 |
| 2011-05-24 | Valenzano Ken (VP, Pharmacology & Biology) | Option Exercise | 2,250 | .64 | 1,435 |
| 2010-03-02 | Crowley John F (Chairman, President & CEO) | Purchase | 11,898 | 3.69 | 43,903 |
| 2009-11-04 | Barer Sol J (Director) | Purchase | 20,000 | 4.13 | 82,600 |
| 2009-07-16 | Crowley John F (President & CEO) | Sale | 3,500 | 10.29 | 36,001 |
| 2009-07-15 | Crowley John F (President & CEO) | Sale | 6,500 | 10.69 | 69,472 |
| 2009-07-14 | Crowley John F (President & CEO) | Sale | 4,748 | 10.28 | 48,818 |
| 2009-07-13 | Crowley John F (President & CEO) | Sale | 800 | 10.09 | 8,068 |
| 2009-07-10 | Crowley John F (President & CEO) | Sale | 200 | 10.06 | 2,011 |
| 2009-07-09 | Crowley John F (President & CEO) | Sale | 1,652 | 10.24 | 16,918 |
| 2009-07-08 | Crowley John F (President & CEO) | Sale | 12,900 | 11.32 | 145,976 |
| 2009-07-07 | Crowley John F (President & CEO) | Sale | 6,200 | 11.42 | 70,785 |
| 2009-07-06 | Crowley John F (President & CEO) | Sale | 13,500 | 11.00 | 148,554 |
| 2009-06-29 | Palling David (Sr VP, Technical Operations) | Sale | 2,500 | 10.54 | 26,347 |
| 2009-06-26 | Palling David (Sr VP, Technical Operations) | Sale | 7,498 | 10.00 | 74,980 |
| 2009-03-30 | Palling David (Sr VP, Technical Operations) | Sale | 2 | 10.00 | 20 |
| 2009-03-25 | Palling David (Sr VP, Technical Operations) | Sale | 531 | 10.00 | 5,310 |
| 2009-03-23 | Palling David (Sr VP, Technical Operations) | Sale | 1,740 | 10.00 | 17,400 |
| 2009-03-19 | Palling David (Sr VP, Technical Operations) | Sale | 229 | 10.00 | 2,290 |
| 2009-03-11 | Crowley John F (President & CEO) | Option Exercise | 1,000 | 5.32 | 5,325 |
| 2009-02-11 | Bloch Stephen M (Director) | Sale | 1,908 | 9.42 | 17,977 |
| 2009-02-03 | Palling David (Senior VP, Technical Operation) | Sale | 7,500 | 10.00 | 75,000 |
| 2009-01-08 | Palling David (Senior VP, Drug Development) | Option Exercise | 4,924 | .64 | 3,141 |
| 2008-12-08 | Bloch Stephen M (Director) | Sale | 3,000 | 8.54 | 25,614 |
| 2008-12-03 | Bloch Stephen M (Director) | Sale | 25 | 8.50 | 212 |
| 2008-12-02 | Patterson Matthew R (Chief Operating Officer) | Option Exercise | 20,098 | .64 | 12,822 |
| 2008-12-02 | Bloch Stephen M (Director) | Sale | 1,544 | 8.50 | 13,124 |
| 2008-12-01 | Bloch Stephen M (Director) | Sale | 4 | 8.90 | 35 |
| 2008-11-28 | Bloch Stephen M (Director) | Sale | 3,000 | 8.50 | 25,500 |
| 2008-11-26 | Bloch Stephen M (Director) | Sale | 3,000 | 8.52 | 25,551 |
| 2008-11-24 | Bloch Stephen M (Director) | Sale | 3,000 | 8.52 | 25,557 |
| 2008-11-21 | Bloch Stephen M (Director) | Sale | 2,436 | 8.50 | 20,706 |
| 2008-11-20 | Bloch Stephen M (Director) | Sale | 3,000 | 8.83 | 26,502 |
| 2008-11-19 | Bloch Stephen M (Director) | Sale | 3,000 | 9.03 | 27,096 |
| 2008-11-18 | Bloch Stephen M (Director) | Sale | 3,000 | 9.11 | 27,324 |
| 2008-11-17 | Bloch Stephen M (Director) | Sale | 7,740 | 9.02 | 69,830 |
| 2008-11-14 | Bloch Stephen M (Director) | Sale | 3,800 | 9.34 | 35,499 |
| 2008-11-13 | Bloch Stephen M (Director) | Sale | 3,000 | 9.41 | 28,218 |
| 2008-11-12 | Bloch Stephen M (Director) | Sale | 3,000 | 9.58 | 28,740 |
| 2008-11-11 | Bloch Stephen M (Director) | Sale | 3,000 | 9.20 | 27,597 |
| 2008-11-10 | Bloch Stephen M (Director) | Sale | 3,000 | 8.98 | 26,936 |
| 2008-11-07 | Bloch Stephen M (Director) | Sale | 3,000 | 9.08 | 27,240 |
| 2008-11-06 | Bloch Stephen M (Director) | Sale | 3,000 | 9.24 | 27,732 |
| 2008-11-05 | Bloch Stephen M (Director) | Sale | 3,900 | 10.04 | 39,163 |
| 2008-11-04 | Bloch Stephen M (Director) | Sale | 3,800 | 10.54 | 40,067 |
| 2008-11-03 | Crowley John F (President & CEO) | Sale | 10,000 | 10.28 | 102,780 |
| 2008-11-03 | Bloch Stephen M (Director) | Sale | 3,000 | 10.24 | 30,720 |
| 2008-10-31 | Palling David (Senior VP, Drug Development) | Sale | 2,200 | 10.00 | 22,000 |
| 2008-10-31 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,939 | 10.00 | 19,390 |
| 2008-10-31 | Bloch Stephen M (Director) | Sale | 3,000 | 9.85 | 29,550 |
| 2008-10-30 | Palling David (Senior VP, Drug Development) | Sale | 300 | 10.00 | 3,000 |
| 2008-10-30 | Patterson Matthew R (Chief Operating Officer) | Sale | 361 | 10.00 | 3,610 |
| 2008-10-30 | Bloch Stephen M (Director) | Sale | 3,000 | 9.54 | 28,626 |
| 2008-10-29 | Bloch Stephen M (Director) | Sale | 3,000 | 8.51 | 25,539 |
| 2008-10-28 | Crowley John F (President & CEO) | Option Exercise | 40,000 | 2.98 | 119,240 |
| 2008-10-28 | Bloch Stephen M (Director) | Sale | 2,601 | 8.50 | 22,108 |
| 2008-10-27 | Bloch Stephen M (Director) | Sale | 2,942 | 8.88 | 26,139 |
| 2008-10-24 | Bloch Stephen M (Director) | Sale | 3,000 | 9.70 | 29,097 |
| 2008-10-23 | Patterson Matthew R (Chief Operating Officer) | Sale | 100 | 10.10 | 1,010 |
| 2008-10-23 | Bloch Stephen M (Director) | Sale | 3,000 | 9.76 | 29,265 |
| 2008-10-22 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,100 | 10.40 | 32,246 |
| 2008-10-22 | Bloch Stephen M (Director) | Sale | 3,000 | 10.48 | 31,425 |
| 2008-10-21 | Patterson Matthew R (Chief Operating Officer) | Sale | 5,000 | 10.50 | 52,524 |
| 2008-10-21 | Bloch Stephen M (Director) | Sale | 3,000 | 10.51 | 31,539 |
| 2008-10-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,000 | 11.12 | 44,484 |
| 2008-10-20 | Bloch Stephen M (Director) | Sale | 6,000 | 10.59 | 63,522 |
| 2008-10-17 | Bloch Stephen M (Director) | Sale | 6,000 | 10.75 | 64,494 |
| 2008-10-16 | Bloch Stephen M (Director) | Sale | 3,000 | 10.51 | 31,536 |
| 2008-10-15 | Bloch Stephen M (Director) | Sale | 3,000 | 11.02 | 33,066 |
| 2008-10-14 | Bloch Stephen M (Director) | Sale | 3,000 | 12.41 | 37,218 |
| 2008-10-13 | Bloch Stephen M (Director) | Sale | 3,000 | 13.17 | 39,501 |
| 2008-10-06 | Crowley John F (President & CEO) | Sale | 2,300 | 14.76 | 33,936 |
| 2008-10-03 | Crowley John F (President & CEO) | Sale | 3,700 | 14.97 | 55,377 |
| 2008-10-02 | Crowley John F (President & CEO) | Sale | 5,200 | 15.10 | 78,498 |
| 2008-10-01 | Crowley John F (President & CEO) | Sale | 2,800 | 15.08 | 42,226 |
| 2008-09-29 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 15.62 | 39,062 |
| 2008-09-22 | Bloch Stephen M (Director) | Sale | 2,829 | 16.02 | 45,312 |
| 2008-09-19 | Bloch Stephen M (Director) | Sale | 11,129 | 16.42 | 182,727 |
| 2008-09-18 | Bloch Stephen M (Director) | Sale | 3,300 | 15.02 | 49,556 |
| 2008-09-17 | Bloch Stephen M (Director) | Sale | 3,000 | 14.13 | 42,387 |
| 2008-09-16 | Bloch Stephen M (Director) | Sale | 3,000 | 14.13 | 42,378 |
| 2008-09-15 | Bloch Stephen M (Director) | Sale | 4,400 | 14.07 | 61,912 |
| 2008-09-12 | Bloch Stephen M (Director) | Sale | 3,000 | 14.09 | 42,279 |
| 2008-09-11 | Bloch Stephen M (Director) | Sale | 3,000 | 14.71 | 44,133 |
| 2008-09-10 | Bloch Stephen M (Director) | Sale | 3,000 | 13.78 | 41,325 |
| 2008-09-09 | Bloch Stephen M (Director) | Sale | 5,700 | 13.79 | 78,597 |
| 2008-09-08 | Palling David (Senior VP, Drug Development) | Sale | 3,000 | 14.83 | 44,496 |
| 2008-09-08 | Bloch Stephen M (Director) | Sale | 3,000 | 14.91 | 44,733 |
| 2008-09-05 | Crowley John F (President and CEO) | Sale | 2,500 | 13.74 | 34,355 |
| 2008-09-05 | Bloch Stephen M (Director) | Sale | 3,000 | 13.75 | 41,250 |
| 2008-09-04 | Crowley John F (President and CEO) | Sale | 2,500 | 13.84 | 34,597 |
| 2008-09-04 | Bloch Stephen M (Director) | Sale | 3,000 | 13.76 | 41,271 |
| 2008-09-03 | Crowley John F (President & CEO) | Sale | 2,500 | 13.76 | 34,412 |
| 2008-09-03 | Bloch Stephen M (Director) | Sale | 3,000 | 13.72 | 41,172 |
| 2008-09-02 | Crowley John F (President & CEO) | Sale | 2,600 | 13.78 | 35,838 |
| 2008-09-02 | Bloch Stephen M (Director) | Sale | 6,000 | 3,463.36 | 20,780,154 |
| 2008-08-29 | Bloch Stephen M (Director) | Sale | 6,000 | 13.79 | 82,758 |
| 2008-08-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 13.77 | 34,425 |
| 2008-08-28 | Bloch Stephen M (Director) | Sale | 3,000 | 13.81 | 41,427 |
| 2008-08-27 | Bloch Stephen M (Director) | Sale | 3,000 | 13.90 | 41,685 |
| 2008-08-26 | Crowley John F (President and CEO) | Sale | 13,333 | 13.61 | 181,475 |
| 2008-08-26 | Bloch Stephen M (Director) | Sale | 4,200 | 13.64 | 57,283 |
| 2008-08-25 | Bloch Stephen M (Director) | Sale | 3,000 | 13.67 | 41,004 |
| 2008-08-22 | Bloch Stephen M (Director) | Sale | 3,000 | 13.52 | 40,569 |
| 2008-08-21 | Bloch Stephen M (Director) | Sale | 3,000 | 13.57 | 40,719 |
| 2008-08-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 2,000 | 13.54 | 27,070 |
| 2008-08-20 | Bloch Stephen M (Director) | Sale | 3,000 | 13.72 | 41,160 |
| 2008-08-19 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,500 | 14.10 | 63,468 |
| 2008-08-19 | Bloch Stephen M (Director) | Sale | 3,000 | 13.56 | 40,671 |
| 2008-08-18 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,500 | 15.53 | 54,358 |
| 2008-08-18 | Licholai Gregory P (VP, Medical Affairs) | Sale | 1,401 | 15.11 | 21,163 |
| 2008-08-18 | Licholai Gregory P (VP, Medical Affairs) | Option Exercise | 1,401 | .64 | 892 |
| 2008-08-18 | Bloch Stephen M (Director) | Sale | 3,000 | 15.14 | 45,420 |
| 2008-08-15 | Bloch Stephen M (Director) | Sale | 3,000 | 16.46 | 49,382 |
| 2008-08-15 | Sblendorio Glenn (Director) | Sale | 1,400 | 16.74 | 23,438 |
| 2008-08-14 | Weinhoff Gregory M (Director) | Sale | 50,000 | 17.00 | 850,000 |
| 2008-08-14 | Bloch Stephen M (Director) | Sale | 10,066 | 17.03 | 171,444 |
| 2008-08-13 | Schaeffer Orlov S Nicole (Sr. VP, HR & Lead.Devlop.) | Sale | 5 | 18.00 | 90 |
| 2008-08-13 | Bloch Stephen M (Director) | Sale | 5,700 | 17.57 | 100,154 |
| 2008-08-12 | Schaeffer Orlov S Nicole (Sr. VP, HR & Lead.Devlop.) | Sale | 208 | 18.00 | 3,744 |
| 2008-08-12 | Bloch Stephen M (Director) | Sale | 7,620 | 16.97 | 129,288 |
| 2008-08-11 | Bloch Stephen M (Director) | Sale | 3,500 | 16.82 | 58,859 |
| 2008-08-08 | Bloch Stephen M (Director) | Sale | 3,000 | 16.70 | 50,091 |
| 2008-08-07 | Bloch Stephen M (Director) | Sale | 4,200 | 16.58 | 69,636 |
| 2008-08-06 | Bloch Stephen M (Director) | Sale | 4,879 | 16.18 | 78,942 |
| 2008-08-05 | Bloch Stephen M (Director) | Sale | 3,000 | 15.55 | 46,662 |
| 2008-08-04 | Crowley John F (President & CEO) | Sale | 6,200 | 15.24 | 94,500 |
| 2008-08-04 | Bloch Stephen M (Director) | Sale | 4,500 | 15.23 | 68,553 |
| 2008-08-01 | Crowley John F (President & CEO) | Sale | 3,800 | 15.42 | 58,603 |
| 2008-08-01 | Bloch Stephen M (Director) | Sale | 3,700 | 15.45 | 57,168 |
| 2008-07-31 | Bloch Stephen M (Director) | Sale | 10,000 | 7,740.23 | 77,402,320 |
| 2008-07-30 | Bloch Stephen M (Director) | Sale | 4,700 | 15.18 | 71,369 |
| 2008-07-29 | Bloch Stephen M (Director) | Sale | 3,600 | 15.30 | 55,087 |
| 2008-07-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 15.08 | 37,692 |
| 2008-07-28 | Bloch Stephen M (Director) | Sale | 9,000 | 15.22 | 137,025 |
| 2008-07-25 | Bloch Stephen M (Director) | Sale | 2,300 | 15.43 | 35,493 |
| 2008-07-24 | Bloch Stephen M (Director) | Sale | 5,661 | 15.24 | 86,245 |
| 2008-07-23 | Bloch Stephen M (Director) | Sale | 1,834 | 15.00 | 27,506 |
Go to page: 1
2
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Amicus Therapeutics Inc (symbol FOLD,
CIK number 1178879) see
the Securities and Exchange Commission (SEC) website.
|
|
